Quote:

---

but I haven't heard management say they even HAVE 42 data, let alone 60 day. Where did we hear that from.

---

They haven't said that. I was assuming for a moment that it was true, in order to engage in dialog with MDV. Just speculating.

Quote:

---

Meanwhile, I've heard it bruited about on the board that everyone in the SOC arm after the last patient was 28 days out was then given Leron -- which if true would mean there was no 42 or 60 day data for the last patients

---

This has not been confirmed either, but assumed that patients that were on Placebo would receive Leronlimab, as they were already qualified for the trial. I believe Borel Fields has pointed out that we would be able to add in 42 or 60 day data from patients that had passed those dates prior to the OLE authorization. Anyone from the placebo group who didnt make it to 42/60 days prior to receiving Leronlimab would not be counted.